Intravenous immunoglobulin (IVIg), is an effective anti-inflammatory and immunomodulatory treatment for many autoimmune diseases. In this Review, Lünemann and colleagues catalogue the evidence to ...

Opportunities in the iron drugs market include developing next-gen formulations to address global anemia, innovating in ...

Intravenous Catheters Market Driven by Rising Chronic Disease Prevalence and Growing Demand for Outpatient and Home-based IV Therapies.Austin, Aug. 19, 2025 (GLOBE NEWSWIRE) -- Intravenous Catheters ...

In accordance with the patent settlement agreement with Genentech, the IV formulation of AVTOZMA is expected to be available in the U.S. on August 31, 2025. Celltrion holds a license to market the ...

PURPOSEPhase III studies of intravenous amivantamab demonstrated efficacy across epidermal growth factor receptor (EGFR)–mutated advanced non–small cell lung cancer (NSCLC). A subcutaneous formulation ...

Studies that have evaluated the use of intravenous vitamin C in adults with sepsis who were receiving vasopressor therapy in the intensive care unit (ICU) have shown mixed results with respect to t ...

Intravenous and Subcutaneous Immunoglobulin Treatment Options Am J Manag Care. 2019;25:-S0 Immunoglobulin (Ig) has provided lifesaving therapy for a range of primary immunodeficiency diseases.

Intravenous tissue plasminogen activator (t-PA; alteplase [Activase, Genentech, or Actilyse, Boehringer Ingelheim]) is the only proven reperfusion therapy for acute ischemic stroke, and its ...

Publisher’s Note The April 10, 2009, article by Stewart et al, entitled, “Phase III Study of Gefitinib Compared With Intravenous Methotrexate for Recurrent Squamous Cell Carcinoma of the Head and Neck ...

Shareholders of Intravenous Infusions PLC has approved the rights issue to raise GH¢50 million to recapitalise the operations of ...